Matthew Doctor - 22 Nov 2024 Form 4 Insider Report for REGIS CORP (RGS)

Reporting relationship: President and CEO, Director
Issuer ticker: RGS
Reported as of: 22 Nov 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Nov 2024, 17:23:15 UTC
Prior SEC filing: 19 Nov 2024
Source filing: View source filing
Reporting owner signature: /s/ Amy Seidel, by power-of-attorney

Key filing fact

Matthew Doctor filed Form 4 for REGIS CORP (RGS) on 26 Nov 2024.

Key facts

This page summarizes Matthew Doctor's Form 4 filing for REGIS CORP (RGS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Nov 2024, 17:23.

Change

Previous filing in this sequence was filed on 19 Nov 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RGS transaction

Common Stock

Award

Transaction value: $0
Shares: +16,500
Change %: +535%
Price: $0.000000
Shares after: 19,584
Date: 22 Nov 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The award vests as to 1/3 of the shares on the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued employment with the Issuer through such anniversaries and the other terms and conditions of the grant agreements.